Innovative Delivery Focus Outplay Inc. specializes in transdermal delivery of peptides and biologics, presenting opportunities to partner with pharmaceutical and biotech companies seeking novel drug delivery solutions and formulations in this emerging area.

Early-Stage Growth With a revenue of less than 1 million dollars and recent funding of 100K, Outplay is an emerging player, open to strategic investments or collaborations that can accelerate product development and market entry.

Research Expertise As a science-driven organization with a growing IP portfolio, Outplay offers chances for licensing, joint research ventures, and technology partnerships with companies seeking innovative biotech solutions.

Niche Market Potential Operating in the specialized biotech sector with fewer than 50 employees, Outplay presents opportunities for boutique or niche biotech firms to acquire or collaborate on cutting-edge transdermal delivery technologies.

Partnership Expansion With an expanding network of partners and licensees and a global positioning goal, Outplay is well-positioned for strategic alliances, joint ventures, and licensing deals in the biotech and pharmaceutical industries.